You are here

Home

Clinical Trials: Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, January 26, 2023 - 12:00
Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke
Condition:   Ischemic Stroke
Intervention:   Biological: MSC
Sponsor:   Shanghai IxCell Biotechnology Co., LTD
Not yet recruiting
Posted: Thursday, January 26, 2023 - 12:00
Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson Disease
Condition:   Parkinson Disease
Intervention:   Dietary Supplement: StemRegen product
Sponsor:   Sociedad Española de Medicina Regenerativa y Terapia Celular
Recruiting
Posted: Thursday, January 26, 2023 - 12:00
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSA
Conditions:   Multiple System Atrophy;   MSA - Multiple System Atrophy
Interventions:   Drug: hOMSC300;   Other: Sham Procedure
Sponsor:   Cytora Ltd.
Recruiting
Posted: Friday, January 20, 2023 - 12:00
Cord Blood Cells in Patients With Acute SCI
Condition:   Spinal Cord Injury, Acute
Interventions:   Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells;   Other: Control vehicle (sterile saline)
Sponsors:   Sklifosovsky Institute of Emergency Care;   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   K.L. Hetagurov North-Osetian State University
Recruiting
Posted: Thursday, January 19, 2023 - 12:00
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease.
Condition:   Idiopathic Parkinson's Disease
Intervention:   Biological: hAESCs
Sponsors:   Shanghai East Hospital;   Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Not yet recruiting
Posted: Wednesday, December 28, 2022 - 12:00
RB-ADSC for Treatment of Mild to Moderate Alzheimer's Disease
Condition:   Alzheimer Disease
Intervention:   Biological: RB-ADSC
Sponsor:   Regeneration Biomedical, Inc.
Not yet recruiting
Posted: Friday, December 2, 2022 - 12:00
A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease
Condition:   Parkinson Disease
Intervention:   Biological: STEM-PD
Sponsors:   Region Skane;   Lund University;   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge
Not yet recruiting
Posted: Wednesday, November 9, 2022 - 12:00
Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting
Conditions:   Romberg Disease;   Craniofacial Microsomia;   Burn Scar;   Post-Traumatic Scar (Disorder)
Interventions:   Biological: Cultured ASCs enrichment fat grafting;   Biological: Curcumin-preconditioned ASCs enrichment fat grafting;   Other: Conventional fat grafting
Sponsors:   University of the Punjab;   Centre of Excellence in Molecular Biology, University of the Punjab, Lahore;   Higher Education Commission (Pakistan);   Jinnah Burn and Reconstructive Surgery Centre, Lahore
Recruiting
Posted: Friday, September 23, 2022 - 12:00
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Conditions:   Spinal Cord Injuries;   Tetraplegia
Intervention:   Device: Testing of MyHand-SCI Device
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
Posted: Thursday, September 15, 2022 - 12:00
A Multi-center, Randomized, Double-blind, Phase 2 Study, Evaluating JCPyV-specific T Cell Therapy for the Treatment of PML
Condition:   Progressive Multifocal Leukoencephalopathy
Intervention:   Biological: CE-VST01-JC
Sponsor:   Cellevolve Bio Inc
Not yet recruiting

Pages